Indivior said on Wednesday its 2018 revenue and adjusted net income would come in below its forecast, hurt by the launch of generic versions of its bestselling opioid addiction treatment in the United States.
from Reuters: Money News https://ift.tt/2L7XKmP
via
IFTTT
0 comments: